| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phenylketonurias | 43 | 2023 | 122 | 8.520 |
Why?
|
| Neonatal Screening | 25 | 2021 | 591 | 3.680 |
Why?
|
| Phenylalanine | 27 | 2021 | 365 | 2.920 |
Why?
|
| Galactosemias | 12 | 2021 | 125 | 2.460 |
Why?
|
| Metabolism, Inborn Errors | 10 | 2016 | 288 | 1.410 |
Why?
|
| Urea Cycle Disorders, Inborn | 3 | 2019 | 31 | 1.320 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 5 | 2022 | 255 | 1.220 |
Why?
|
| Parents | 13 | 2021 | 3405 | 1.110 |
Why?
|
| Phenylketonuria, Maternal | 9 | 2003 | 15 | 1.040 |
Why?
|
| Diet, Protein-Restricted | 2 | 2021 | 71 | 0.920 |
Why?
|
| UTP-Hexose-1-Phosphate Uridylyltransferase | 5 | 2021 | 68 | 0.880 |
Why?
|
| Acyl-CoA Dehydrogenase | 7 | 2017 | 58 | 0.870 |
Why?
|
| Methylmalonyl-CoA Mutase | 1 | 2022 | 22 | 0.850 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2021 | 27 | 0.820 |
Why?
|
| Child Development | 9 | 2021 | 2223 | 0.710 |
Why?
|
| Food Preferences | 1 | 2023 | 399 | 0.710 |
Why?
|
| Intelligence | 17 | 2010 | 920 | 0.700 |
Why?
|
| Pregnancy Complications | 19 | 2017 | 2861 | 0.700 |
Why?
|
| Lipid Metabolism, Inborn Errors | 4 | 2017 | 119 | 0.680 |
Why?
|
| Citrullinemia | 1 | 2018 | 2 | 0.650 |
Why?
|
| Argininosuccinic Aciduria | 1 | 2018 | 10 | 0.640 |
Why?
|
| Hyperargininemia | 1 | 2018 | 12 | 0.640 |
Why?
|
| Developmental Disabilities | 9 | 2020 | 1456 | 0.630 |
Why?
|
| Cognition | 12 | 2021 | 6770 | 0.600 |
Why?
|
| Diet Surveys | 1 | 2021 | 1173 | 0.590 |
Why?
|
| Infant, Newborn | 45 | 2021 | 25628 | 0.580 |
Why?
|
| Angelman Syndrome | 6 | 2019 | 136 | 0.550 |
Why?
|
| Metabolic Diseases | 4 | 2017 | 658 | 0.490 |
Why?
|
| Child | 54 | 2023 | 77709 | 0.450 |
Why?
|
| Neuropsychological Tests | 14 | 2020 | 6994 | 0.440 |
Why?
|
| Child, Preschool | 34 | 2021 | 41005 | 0.440 |
Why?
|
| Genetic Testing | 3 | 2018 | 3444 | 0.440 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 4 | 2021 | 3658 | 0.420 |
Why?
|
| Intelligence Tests | 8 | 2019 | 505 | 0.410 |
Why?
|
| Mothers | 6 | 2021 | 2165 | 0.410 |
Why?
|
| Stress, Psychological | 5 | 2016 | 4245 | 0.400 |
Why?
|
| Family Health | 2 | 2006 | 1281 | 0.390 |
Why?
|
| Mitochondrial Diseases | 2 | 2017 | 320 | 0.360 |
Why?
|
| Alleles | 1 | 2021 | 6933 | 0.360 |
Why?
|
| Cognition Disorders | 8 | 2012 | 4043 | 0.330 |
Why?
|
| Hyperammonemia | 3 | 2019 | 76 | 0.330 |
Why?
|
| Infant | 27 | 2021 | 35134 | 0.330 |
Why?
|
| Postpartum Period | 1 | 2014 | 1086 | 0.320 |
Why?
|
| False Positive Reactions | 6 | 2009 | 980 | 0.310 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2021 | 3922 | 0.310 |
Why?
|
| Adolescent | 40 | 2021 | 85779 | 0.290 |
Why?
|
| Glutamine | 3 | 2018 | 579 | 0.290 |
Why?
|
| Pregnancy Outcome | 12 | 2004 | 2795 | 0.290 |
Why?
|
| Rare Diseases | 3 | 2019 | 553 | 0.280 |
Why?
|
| Humans | 118 | 2023 | 744366 | 0.280 |
Why?
|
| Female | 86 | 2021 | 380193 | 0.280 |
Why?
|
| Social Support | 8 | 2004 | 2118 | 0.280 |
Why?
|
| Prenatal Care | 3 | 2004 | 1092 | 0.280 |
Why?
|
| Genetic Variation | 1 | 2021 | 6542 | 0.270 |
Why?
|
| Infant, Newborn, Diseases | 3 | 2009 | 582 | 0.270 |
Why?
|
| Homocystinuria | 3 | 2019 | 67 | 0.270 |
Why?
|
| Betaine | 2 | 2019 | 87 | 0.270 |
Why?
|
| Adult | 56 | 2021 | 214052 | 0.260 |
Why?
|
| Chromosomes, Human, Pair 15 | 4 | 2011 | 373 | 0.260 |
Why?
|
| Family Practice | 1 | 2008 | 516 | 0.250 |
Why?
|
| Methylmalonic Acid | 2 | 2022 | 49 | 0.250 |
Why?
|
| Fatty Acids | 1 | 2013 | 1809 | 0.250 |
Why?
|
| Patient Compliance | 7 | 2004 | 2684 | 0.240 |
Why?
|
| Social Behavior | 2 | 2011 | 1127 | 0.240 |
Why?
|
| Male | 55 | 2021 | 350115 | 0.240 |
Why?
|
| Prejudice | 1 | 2008 | 570 | 0.230 |
Why?
|
| Research Support as Topic | 1 | 2008 | 705 | 0.230 |
Why?
|
| Sick Role | 1 | 2004 | 237 | 0.230 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 3595 | 0.220 |
Why?
|
| Pregnancy | 31 | 2017 | 29144 | 0.220 |
Why?
|
| Homozygote | 3 | 2019 | 1787 | 0.220 |
Why?
|
| Histidine | 1 | 2004 | 313 | 0.220 |
Why?
|
| Research Personnel | 1 | 2008 | 573 | 0.220 |
Why?
|
| Glutarates | 1 | 2004 | 236 | 0.220 |
Why?
|
| Attitude to Health | 6 | 2018 | 2052 | 0.210 |
Why?
|
| Executive Function | 3 | 2020 | 1364 | 0.210 |
Why?
|
| Longitudinal Studies | 13 | 2019 | 13991 | 0.200 |
Why?
|
| Physicians, Women | 1 | 2008 | 486 | 0.200 |
Why?
|
| Phenylalanine Hydroxylase | 2 | 2018 | 30 | 0.200 |
Why?
|
| Fetal Diseases | 4 | 2004 | 903 | 0.200 |
Why?
|
| Translations | 1 | 2021 | 64 | 0.200 |
Why?
|
| Mental Disorders | 5 | 2019 | 6598 | 0.200 |
Why?
|
| Peer Group | 2 | 2004 | 635 | 0.200 |
Why?
|
| Europe | 2 | 2019 | 3338 | 0.190 |
Why?
|
| Quality Improvement | 1 | 2016 | 3749 | 0.190 |
Why?
|
| Phenotype | 10 | 2021 | 16367 | 0.190 |
Why?
|
| Child Behavior | 2 | 2003 | 839 | 0.180 |
Why?
|
| Faculty, Medical | 1 | 2008 | 1181 | 0.170 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 1999 | 37 | 0.170 |
Why?
|
| Fellowships and Scholarships | 1 | 2008 | 1078 | 0.170 |
Why?
|
| Mitochondrial Myopathies | 1 | 1999 | 47 | 0.170 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2019 | 23 | 0.170 |
Why?
|
| Young Adult | 14 | 2020 | 56429 | 0.170 |
Why?
|
| Vitamin B 12 | 1 | 2022 | 527 | 0.170 |
Why?
|
| Arginine | 2 | 2018 | 944 | 0.170 |
Why?
|
| Folic Acid | 2 | 2019 | 1300 | 0.170 |
Why?
|
| Genotype | 7 | 2021 | 12952 | 0.160 |
Why?
|
| Follow-Up Studies | 11 | 2021 | 39052 | 0.160 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 2019 | 142 | 0.160 |
Why?
|
| Parenting | 1 | 2004 | 679 | 0.160 |
Why?
|
| Neurites | 1 | 2020 | 388 | 0.160 |
Why?
|
| Citrulline | 1 | 2018 | 105 | 0.150 |
Why?
|
| Tyrosinemias | 1 | 2017 | 10 | 0.150 |
Why?
|
| Emotions | 1 | 2010 | 2659 | 0.150 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2019 | 433 | 0.150 |
Why?
|
| Ammonia | 1 | 2018 | 239 | 0.150 |
Why?
|
| Language Development Disorders | 2 | 2013 | 196 | 0.140 |
Why?
|
| Mutagenesis, Insertional | 1 | 2019 | 655 | 0.140 |
Why?
|
| Diet Therapy | 2 | 2017 | 154 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2021 | 17446 | 0.140 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2020 | 587 | 0.140 |
Why?
|
| Depression, Postpartum | 1 | 2021 | 340 | 0.140 |
Why?
|
| Age of Onset | 2 | 2019 | 3270 | 0.140 |
Why?
|
| Adaptation, Psychological | 3 | 2021 | 2575 | 0.140 |
Why?
|
| Psychometrics | 4 | 2020 | 3003 | 0.140 |
Why?
|
| Carnitine | 2 | 2017 | 246 | 0.130 |
Why?
|
| Statistics, Nonparametric | 5 | 2011 | 2887 | 0.130 |
Why?
|
| Mother-Child Relations | 1 | 1999 | 481 | 0.130 |
Why?
|
| Canada | 2 | 2017 | 2065 | 0.120 |
Why?
|
| Membrane Transport Proteins | 1 | 2019 | 1031 | 0.120 |
Why?
|
| Mental Processes | 1 | 1994 | 249 | 0.110 |
Why?
|
| United States | 10 | 2023 | 69872 | 0.110 |
Why?
|
| Coma | 1 | 2017 | 475 | 0.110 |
Why?
|
| Depression | 3 | 2021 | 7759 | 0.110 |
Why?
|
| Middle Aged | 13 | 2021 | 213390 | 0.110 |
Why?
|
| Home Care Services | 1 | 1999 | 606 | 0.110 |
Why?
|
| Motor Skills Disorders | 1 | 2013 | 90 | 0.110 |
Why?
|
| Pregnancy in Diabetics | 1 | 1993 | 179 | 0.110 |
Why?
|
| Hypothyroidism | 3 | 2003 | 658 | 0.100 |
Why?
|
| Psychological Tests | 3 | 2007 | 651 | 0.100 |
Why?
|
| Family Planning Services | 2 | 1993 | 263 | 0.100 |
Why?
|
| Mutation | 6 | 2022 | 29786 | 0.100 |
Why?
|
| Congenital Abnormalities | 3 | 2000 | 707 | 0.100 |
Why?
|
| Patient Education as Topic | 2 | 1999 | 2278 | 0.100 |
Why?
|
| Thyroxine | 3 | 2011 | 667 | 0.100 |
Why?
|
| Galactose | 3 | 2019 | 306 | 0.090 |
Why?
|
| Agoraphobia | 1 | 1991 | 179 | 0.090 |
Why?
|
| Neurologic Examination | 2 | 2008 | 931 | 0.090 |
Why?
|
| Case-Control Studies | 9 | 2020 | 21748 | 0.090 |
Why?
|
| Sequence Deletion | 2 | 2019 | 1525 | 0.090 |
Why?
|
| Analysis of Variance | 4 | 2004 | 6366 | 0.090 |
Why?
|
| Medical Records | 2 | 2013 | 1413 | 0.090 |
Why?
|
| Anxiety | 2 | 2019 | 4293 | 0.090 |
Why?
|
| Erythrocytes | 1 | 2019 | 2455 | 0.090 |
Why?
|
| Personality Disorders | 1 | 1994 | 713 | 0.090 |
Why?
|
| Contraception Behavior | 1 | 1991 | 185 | 0.080 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2011 | 732 | 0.080 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2020 | 2737 | 0.080 |
Why?
|
| Retrospective Studies | 9 | 2021 | 77460 | 0.080 |
Why?
|
| Interviews as Topic | 3 | 2009 | 2539 | 0.080 |
Why?
|
| Death, Sudden | 1 | 2010 | 302 | 0.080 |
Why?
|
| Cross-Sectional Studies | 4 | 2023 | 25039 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 2 | 2018 | 4805 | 0.080 |
Why?
|
| Tyrosine | 3 | 2010 | 1462 | 0.080 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2008 | 117 | 0.080 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2011 | 2408 | 0.080 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 2184 | 0.070 |
Why?
|
| MMPI | 2 | 1999 | 86 | 0.070 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2011 | 1862 | 0.070 |
Why?
|
| Time Factors | 5 | 2016 | 40075 | 0.070 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2008 | 350 | 0.070 |
Why?
|
| Mass Spectrometry | 3 | 2003 | 2204 | 0.070 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2017 | 3759 | 0.070 |
Why?
|
| Quality of Life | 3 | 2022 | 12802 | 0.070 |
Why?
|
| Personality | 2 | 1993 | 552 | 0.070 |
Why?
|
| Fetal Blood | 3 | 1990 | 1318 | 0.070 |
Why?
|
| Treatment Outcome | 7 | 2019 | 63107 | 0.070 |
Why?
|
| Nervous System | 1 | 2010 | 554 | 0.070 |
Why?
|
| Databases, Bibliographic | 1 | 2006 | 128 | 0.070 |
Why?
|
| Pregnancy Trimester, First | 1 | 2010 | 853 | 0.070 |
Why?
|
| Birth Weight | 6 | 2004 | 2069 | 0.070 |
Why?
|
| Galactosephosphates | 1 | 2004 | 9 | 0.060 |
Why?
|
| Galactitol | 1 | 2004 | 6 | 0.060 |
Why?
|
| Diet | 1 | 2023 | 7937 | 0.060 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2007 | 256 | 0.060 |
Why?
|
| Brain Mapping | 1 | 2020 | 6670 | 0.060 |
Why?
|
| Communication | 3 | 2008 | 3750 | 0.060 |
Why?
|
| Massachusetts | 2 | 2016 | 8662 | 0.060 |
Why?
|
| New England | 3 | 2001 | 1022 | 0.060 |
Why?
|
| Genetic Counseling | 2 | 2018 | 600 | 0.060 |
Why?
|
| Chromosome Aberrations | 1 | 2011 | 1813 | 0.060 |
Why?
|
| Comorbidity | 1 | 2018 | 10388 | 0.060 |
Why?
|
| Health Education | 1 | 1990 | 1056 | 0.060 |
Why?
|
| Depressive Disorder, Major | 1 | 2021 | 4639 | 0.060 |
Why?
|
| Educational Measurement | 1 | 1990 | 1210 | 0.060 |
Why?
|
| Vitamin B Complex | 2 | 2019 | 288 | 0.060 |
Why?
|
| Biotinidase Deficiency | 1 | 2002 | 3 | 0.060 |
Why?
|
| Awards and Prizes | 1 | 2008 | 375 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 12244 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 19905 | 0.060 |
Why?
|
| Program Evaluation | 2 | 2004 | 2488 | 0.050 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2002 | 27 | 0.050 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2002 | 39 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2010 | 1504 | 0.050 |
Why?
|
| Psychomotor Disorders | 1 | 2003 | 152 | 0.050 |
Why?
|
| Genome, Human | 1 | 2016 | 4420 | 0.050 |
Why?
|
| Acyl-CoA Dehydrogenases | 1 | 2002 | 25 | 0.050 |
Why?
|
| Logistic Models | 4 | 2003 | 13409 | 0.050 |
Why?
|
| Chromosome Deletion | 1 | 2007 | 1401 | 0.050 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2003 | 456 | 0.050 |
Why?
|
| Neurodegenerative Diseases | 1 | 2011 | 1061 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2014 | 9849 | 0.050 |
Why?
|
| Prospective Studies | 9 | 2014 | 53290 | 0.050 |
Why?
|
| Disease Progression | 3 | 2016 | 13286 | 0.050 |
Why?
|
| Language Disorders | 1 | 1983 | 141 | 0.050 |
Why?
|
| Head | 3 | 2003 | 880 | 0.050 |
Why?
|
| Speech Disorders | 1 | 1983 | 189 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2016 | 780 | 0.050 |
Why?
|
| Factor Analysis, Statistical | 1 | 2004 | 977 | 0.050 |
Why?
|
| Schools, Medical | 1 | 2008 | 881 | 0.050 |
Why?
|
| Plasma Membrane Neurotransmitter Transport Proteins | 1 | 2020 | 19 | 0.050 |
Why?
|
| Verbal Learning | 1 | 2003 | 468 | 0.050 |
Why?
|
| Iodine | 1 | 2003 | 286 | 0.050 |
Why?
|
| Boston | 2 | 2017 | 9312 | 0.050 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2020 | 44 | 0.050 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2020 | 36 | 0.050 |
Why?
|
| Brain | 3 | 2017 | 26388 | 0.050 |
Why?
|
| DNA Methylation | 2 | 2011 | 4285 | 0.050 |
Why?
|
| Educational Status | 2 | 2007 | 2540 | 0.040 |
Why?
|
| Cystathionine gamma-Lyase | 1 | 1999 | 36 | 0.040 |
Why?
|
| Mitochondria | 1 | 2013 | 3514 | 0.040 |
Why?
|
| Aged | 4 | 2021 | 163288 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2011 | 3296 | 0.040 |
Why?
|
| Child Behavior Disorders | 1 | 2003 | 807 | 0.040 |
Why?
|
| Creatine | 1 | 2020 | 421 | 0.040 |
Why?
|
| Genomic Imprinting | 2 | 2010 | 328 | 0.040 |
Why?
|
| Health Care Costs | 3 | 2018 | 3208 | 0.040 |
Why?
|
| Autistic Disorder | 1 | 2007 | 1185 | 0.040 |
Why?
|
| Electroencephalography | 3 | 2020 | 6151 | 0.040 |
Why?
|
| Enzyme Assays | 1 | 2019 | 111 | 0.040 |
Why?
|
| Nitrobenzoates | 1 | 2017 | 17 | 0.040 |
Why?
|
| Twins, Monozygotic | 1 | 2019 | 458 | 0.040 |
Why?
|
| Cyclohexanones | 1 | 2017 | 30 | 0.040 |
Why?
|
| Sodium Benzoate | 1 | 2017 | 15 | 0.040 |
Why?
|
| Reproduction | 1 | 2002 | 668 | 0.040 |
Why?
|
| Drugs, Investigational | 1 | 2019 | 214 | 0.040 |
Why?
|
| Hydroxyproline | 1 | 1997 | 116 | 0.040 |
Why?
|
| Problem Solving | 1 | 2020 | 440 | 0.040 |
Why?
|
| Memory, Short-Term | 2 | 2020 | 977 | 0.040 |
Why?
|
| Phenylacetates | 1 | 2017 | 114 | 0.040 |
Why?
|
| Double-Blind Method | 3 | 2019 | 12025 | 0.040 |
Why?
|
| Parent-Child Relations | 1 | 2021 | 747 | 0.040 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2017 | 52 | 0.040 |
Why?
|
| Attention | 2 | 2007 | 2397 | 0.040 |
Why?
|
| Anisotropy | 1 | 2020 | 1265 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 7282 | 0.040 |
Why?
|
| Thyroid Gland | 1 | 2003 | 1173 | 0.030 |
Why?
|
| Fetus | 1 | 1983 | 1880 | 0.030 |
Why?
|
| Child Language | 2 | 2010 | 64 | 0.030 |
Why?
|
| Glutamates | 1 | 2017 | 398 | 0.030 |
Why?
|
| Socioeconomic Factors | 2 | 2003 | 7785 | 0.030 |
Why?
|
| Wechsler Scales | 2 | 2007 | 260 | 0.030 |
Why?
|
| Gestational Age | 1 | 2004 | 3493 | 0.030 |
Why?
|
| Remote Sensing Technology | 1 | 2016 | 90 | 0.030 |
Why?
|
| Diseases in Twins | 1 | 1997 | 449 | 0.030 |
Why?
|
| Disease Management | 2 | 2017 | 2460 | 0.030 |
Why?
|
| Gastrointestinal Agents | 1 | 2019 | 494 | 0.030 |
Why?
|
| Propionates | 1 | 1995 | 169 | 0.030 |
Why?
|
| Infant, Premature, Diseases | 1 | 2020 | 707 | 0.030 |
Why?
|
| Sex Factors | 1 | 2008 | 10400 | 0.030 |
Why?
|
| Memory | 1 | 2003 | 2174 | 0.030 |
Why?
|
| Thyrotropin | 3 | 2003 | 849 | 0.030 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 3611 | 0.030 |
Why?
|
| Self-Help Groups | 1 | 1994 | 190 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 12961 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2019 | 1157 | 0.030 |
Why?
|
| Age Factors | 4 | 2011 | 18373 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 2017 | 555 | 0.030 |
Why?
|
| Health Behavior | 1 | 2004 | 2635 | 0.030 |
Why?
|
| Internal-External Control | 1 | 1993 | 363 | 0.030 |
Why?
|
| Informed Consent | 1 | 2018 | 995 | 0.030 |
Why?
|
| Food | 1 | 1997 | 772 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2019 | 1058 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2009 | 5321 | 0.020 |
Why?
|
| Language | 1 | 2020 | 1471 | 0.020 |
Why?
|
| Lipotropic Agents | 1 | 2010 | 14 | 0.020 |
Why?
|
| Data Collection | 3 | 2011 | 3339 | 0.020 |
Why?
|
| Family | 2 | 2018 | 3147 | 0.020 |
Why?
|
| Ovarian Diseases | 1 | 2012 | 139 | 0.020 |
Why?
|
| Uniparental Disomy | 1 | 2010 | 43 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2011 | 683 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2020 | 2045 | 0.020 |
Why?
|
| Reference Values | 2 | 2011 | 4982 | 0.020 |
Why?
|
| Health Status | 1 | 2003 | 4034 | 0.020 |
Why?
|
| Motor Activity | 1 | 2020 | 2715 | 0.020 |
Why?
|
| Disabled Persons | 1 | 1980 | 1212 | 0.020 |
Why?
|
| Pediatrics | 1 | 2005 | 3475 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 14723 | 0.020 |
Why?
|
| Registries | 2 | 2019 | 8091 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 3921 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2019 | 40559 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2004 | 9145 | 0.020 |
Why?
|
| Interpersonal Relations | 2 | 2011 | 1425 | 0.020 |
Why?
|
| Alagille Syndrome | 1 | 2008 | 35 | 0.020 |
Why?
|
| Interinstitutional Relations | 1 | 2010 | 241 | 0.020 |
Why?
|
| Maternal-Child Health Centers | 1 | 1988 | 40 | 0.020 |
Why?
|
| Gastric Bypass | 1 | 2017 | 812 | 0.020 |
Why?
|
| Thyroid Diseases | 1 | 2011 | 379 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2016 | 1584 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1990 | 1681 | 0.020 |
Why?
|
| Facies | 1 | 2008 | 197 | 0.020 |
Why?
|
| Child of Impaired Parents | 1 | 2011 | 455 | 0.020 |
Why?
|
| Self Concept | 1 | 1993 | 1025 | 0.020 |
Why?
|
| Biopsy | 1 | 2019 | 6755 | 0.020 |
Why?
|
| Motor Skills | 1 | 2010 | 522 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2008 | 496 | 0.020 |
Why?
|
| Dietary Carbohydrates | 1 | 2012 | 905 | 0.020 |
Why?
|
| Seizures | 1 | 2019 | 2859 | 0.020 |
Why?
|
| Chromosome Breakage | 1 | 2007 | 173 | 0.020 |
Why?
|
| Internationality | 1 | 2012 | 1002 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2017 | 2119 | 0.020 |
Why?
|
| Patient Selection | 1 | 2018 | 4216 | 0.020 |
Why?
|
| Skin | 1 | 2019 | 4372 | 0.020 |
Why?
|
| Attitude | 1 | 1991 | 776 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2017 | 2063 | 0.020 |
Why?
|
| Placebos | 1 | 2010 | 1676 | 0.020 |
Why?
|
| Creatine Kinase | 1 | 2007 | 694 | 0.020 |
Why?
|
| Genomics | 1 | 2021 | 5717 | 0.020 |
Why?
|
| Health | 1 | 1988 | 394 | 0.020 |
Why?
|
| Personality Tests | 1 | 1984 | 83 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2010 | 1958 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2017 | 1912 | 0.020 |
Why?
|
| Caregivers | 1 | 2016 | 2095 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2019 | 13035 | 0.020 |
Why?
|
| Prognosis | 2 | 2004 | 29060 | 0.010 |
Why?
|
| Hospitalization | 1 | 2003 | 10259 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2008 | 1252 | 0.010 |
Why?
|
| Immunoglobulins, Thyroid-Stimulating | 1 | 2003 | 34 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2008 | 1081 | 0.010 |
Why?
|
| Speech Articulation Tests | 1 | 1983 | 4 | 0.010 |
Why?
|
| Microcephaly | 2 | 1987 | 432 | 0.010 |
Why?
|
| Pregnant Women | 1 | 1988 | 568 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 1988 | 1364 | 0.010 |
Why?
|
| Risk Factors | 5 | 2004 | 72296 | 0.010 |
Why?
|
| Thyroglobulin | 1 | 2003 | 114 | 0.010 |
Why?
|
| Homocystine | 1 | 2002 | 22 | 0.010 |
Why?
|
| Electronic Mail | 1 | 2005 | 213 | 0.010 |
Why?
|
| Amino Acids, Sulfur | 1 | 2002 | 16 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2003 | 438 | 0.010 |
Why?
|
| Language Tests | 1 | 1983 | 202 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2010 | 2751 | 0.010 |
Why?
|
| Pyridoxine | 1 | 2002 | 102 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 10943 | 0.010 |
Why?
|
| Decision Making | 1 | 1995 | 3888 | 0.010 |
Why?
|
| Food, Formulated | 1 | 2002 | 109 | 0.010 |
Why?
|
| Probability | 1 | 1987 | 2506 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 1677 | 0.010 |
Why?
|
| Aging | 1 | 2020 | 8664 | 0.010 |
Why?
|
| Education, Distance | 1 | 2005 | 251 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 2703 | 0.010 |
Why?
|
| Nutritional Status | 2 | 2002 | 1609 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 7914 | 0.010 |
Why?
|
| Cystathionine | 1 | 1999 | 5 | 0.010 |
Why?
|
| State Health Plans | 1 | 2002 | 216 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 18034 | 0.010 |
Why?
|
| Education, Medical, Continuing | 1 | 2005 | 840 | 0.010 |
Why?
|
| Education | 1 | 2002 | 543 | 0.010 |
Why?
|
| Abortion, Spontaneous | 1 | 1983 | 544 | 0.010 |
Why?
|
| Denmark | 1 | 1980 | 738 | 0.010 |
Why?
|
| Body Height | 1 | 2003 | 1578 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 1995 | 5749 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2018 | 23336 | 0.010 |
Why?
|
| Twins, Dizygotic | 1 | 1997 | 236 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2002 | 1608 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1991 | 3338 | 0.010 |
Why?
|
| Cross-Cultural Comparison | 1 | 1980 | 651 | 0.010 |
Why?
|
| Amino Acids | 1 | 2002 | 1737 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2011 | 5101 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 9735 | 0.010 |
Why?
|
| Methylmalonyl-CoA Decarboxylase | 1 | 1995 | 3 | 0.010 |
Why?
|
| Muscle Tonus | 1 | 1995 | 81 | 0.010 |
Why?
|
| Carboxy-Lyases | 1 | 1995 | 90 | 0.010 |
Why?
|
| Delivery, Obstetric | 1 | 2002 | 906 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2008 | 6442 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2002 | 4185 | 0.010 |
Why?
|
| Body Weight | 1 | 1983 | 4671 | 0.010 |
Why?
|
| Gastrostomy | 1 | 1995 | 310 | 0.010 |
Why?
|
| Animals | 2 | 2019 | 168768 | 0.010 |
Why?
|
| Research | 1 | 2000 | 1999 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2008 | 7882 | 0.010 |
Why?
|
| Brain Injuries | 1 | 2003 | 2029 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 1999 | 1901 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2005 | 3841 | 0.010 |
Why?
|
| Insurance Coverage | 1 | 2002 | 1900 | 0.010 |
Why?
|
| Risk | 1 | 1983 | 9688 | 0.010 |
Why?
|
| Enteral Nutrition | 1 | 1995 | 767 | 0.010 |
Why?
|
| Visual Perception | 1 | 1997 | 1420 | 0.000 |
Why?
|
| Health Services Accessibility | 1 | 2002 | 5135 | 0.000 |
Why?
|
| Mice | 1 | 2008 | 81201 | 0.000 |
Why?
|
| Prenatal Diagnosis | 1 | 1987 | 1236 | 0.000 |
Why?
|